Sagi-Assif O, Traister A, Katz B Z, Anavi R, Eskenasy M, Witz I P
Department of Cell Research and Immunology, George S. Wise Faculty of Life Sciences, Tel Aviv University, Israel.
Immunol Lett. 1996 Dec;54(2-3):207-13. doi: 10.1016/s0165-2478(96)02675-2.
Angiogenic and poorly angiogenic tumor variants were obtained by an intraperitoneal inoculation of cells from clones of polyoma-virus transformed BALB/c 3T3 cells into syngeneic mice. The angiogenic tumor cells expressed a higher tumorigenicity phenotype and a higher capacity to produce artificial pulmonary metastases than cells from the poorly angiogenic tumors. The former cells expressed also significantly higher levels of the lymphocyte activation protein Ly-6E.1 than the former cells. The two types of cells did not differ in expression levels of CD44 and of a polyoma-virus specific membrane antigen. These results raise the possibility that the angiogenic phenotype is coregulated with Ly-6. The effect on Ly-6 expression of signal transduction through TNF receptors, functioning as pivotal regulators of angiogenesis was therefore studied. It was found that TNFalpha and more so antibodies against Fas down-regulate expression levels of Ly-6. This down-regulation seemed to be selective as expression levels of CD44 were not affected by this treatment.
通过将多瘤病毒转化的BALB/c 3T3细胞克隆的细胞腹腔接种到同基因小鼠中,获得了血管生成性和低血管生成性肿瘤变体。与低血管生成性肿瘤的细胞相比,血管生成性肿瘤细胞表现出更高的致瘤性表型和产生人工肺转移的能力。前一种细胞还比后一种细胞表达明显更高水平的淋巴细胞激活蛋白Ly-6E.1。这两种细胞在CD44和多瘤病毒特异性膜抗原的表达水平上没有差异。这些结果增加了血管生成表型与Ly-6共同调节的可能性。因此,研究了作为血管生成关键调节因子的通过TNF受体的信号转导对Ly-6表达的影响。发现TNFα以及更多针对Fas的抗体下调Ly-6的表达水平。这种下调似乎具有选择性,因为CD44的表达水平不受该处理的影响。